Danielle Feigenbaum

Danielle Feigenbaum

Clinical Assistant Professor of Neurology (Part-Time)
HCT 1520 San Pablo Street Health Sciences Campus Los Angeles

Cognitive effects of theta frequency bilateral subthalamic nucleus stimulation in Parkinson's disease: A pilot study Brain Stimul. 2021 Mar-Apr; 14(2):230-240. . View in PubMed

Tears - more to them than meets the eye: why tears are a good source of biomarkers in Parkinson's disease Biomark Med. 2020 02; 14(2):151-163. . View in PubMed

Levels of oligomeric a-Synuclein in reflex tears distinguish Parkinson's disease patients from healthy controls Biomark Med. 2019 12; 13(17):1447-1457. . View in PubMed

Oligomeric a-synuclein is increased in basal tears of Parkinson's patients Biomark Med. 2019 08; 13(11):941-952. . View in PubMed

Mechanisms and clinical evidence of the pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in central nervous system disorders: a comprehensive review Int J Neurosci. 2012 Nov; 122(11):619-29. . View in PubMed

Carotid plaque and candidate genes related to inflammation and endothelial function in Hispanics from northern Manhattan Stroke. 2011 Apr; 42(4):889-96. . View in PubMed

A candidate gene study revealed sex-specific association between the OLR1 gene and carotid plaque Stroke. 2011 Mar; 42(3):588-92. . View in PubMed

Dr. Danielle Feigenbaum is a board certified neurologist specializing in Parkinson disease, dystonia, ataxia, chorea, and other movement disorders. In addition to her clinical activities, Dr. Feigenbaum is active in research and education. Her research focuses primarily on finding biomarkers to help diagnose Parkinson’s disease. She also has an interest in a movement rich lifestyle and its beneficial effects in all aspects of life. Dr. Feigenbaum serves as the site investigator for several clinical trials studying new treatments for Parkinson’s disease and dystonia.
sc ctsi logoPowered by SC CTSI